US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,740.61

-86.7209-3.07%

Number of Gainers:1

Number of Losers:4

Number of Flat:- -

PE:- -

High:2,828.84

Open:2,828.59

Low:2,735.72

Close:2,827.33

Volume:6.11M

Turnover:125.17M

Market Cap:43.81B

Float Cap:40.91B

Loading ...

Daré Bioscience DARE-HPV Program Advances with Non-Dilutive US Government Funding

DarÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 over 50: Innovation” List

THOMSON REUTERS

DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List

Veru Chief Scientific Officer Gary Barnette Acquires $4,841.82 in Common Shares

Daré Bioscience Prices USD 6 Million Registered Direct Offering at USD 1.37 Per Share

Teva price target raised to $42 from $40 at Barclays

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)

Femasys Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Evofem Q2 FY26 Net Loss Widens to $8.55 Million; Net Product Sales Fall 45% to $2.63 Million

Femasys Q2 Net Loss Narrows 2.55% to $4.47 Million; Net Sales Drop 18.9% to $331,827

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

THOMSON REUTERS

Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall

MT Newswires Live

Daré Bioscience to Issue Series A, Series B Warrants in Private Placement for up to 8,759,162 Shares

NASDAQ Trade Halt Volatility Trading Pause at 12:45 Pm

DarÉ Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS

Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4584/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2740.6118,"timestamp":1787947199999,"preClose":2827.3328,"halted":0,"volume":6114784,"delay":0,"changeRate":-0.030672,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-86.720947,"latestTime":"08-28 16:00:00 EDT","open":2828.5896,"high":2828.8354,"low":2735.7231,"amount":125165985.278959,"amplitude":0.032933,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.85998,"peRate":72.242284,"turnoverRate":0.004256,"increases":1,"decrements":4,"flats":0,"marketCap":43808477991,"floatMarketCap":40908793934},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2828.8354,"amplitude":0.032933,"preClose":2827.3328,"low":2735.7231,"pbRate":"5.85998","latestPrice":2740.6118,"volume":6114784,"delay":0,"open":2828.5896,"prevYearClose":2379.9924,"prevWeekClose":2809.5261,"prevMonthClose":2636.2712,"prevQuarterClose":2562.5076,"fiveDayClose":2809.5261,"twentyDayClose":2636.2712,"sixtyDayClose":2450.1577,"secType":"PLATE","market":"US","turnoverRate":0.004256,"peRate":72.242284,"marketCap":43808477991,"floatMarketCap":40908793934,"timestamp":1787947199999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":1,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660646700","title":"Daré Bioscience DARE-HPV Program Advances with Non-Dilutive US Government Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2660646700","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660646700?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:04","pubTimestamp":1787058290,"startTime":"0","endTime":"0","summary":"Daré Bioscience DARE-HPV program advances with non-dilutive US government fundingDaré Bioscience said its DARE-HPV program for persistent high-risk HPV is advancing with non-dilutive government fundin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL9RX6Np:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BQXX3F31.USD","SG9999014005.SGD","BCDF","LU2210149790.SGD","BK4584","BK4007","IE00BQXX3D17.EUR","DARE","NDAQ","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4585","BK4112","IE00BKPKM429.USD","SG9999014021.USD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467776","title":"DarÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 over 50: Innovation” List","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467776","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467776?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:02","pubTimestamp":1787058120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA3YN9JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DARE","BK4007","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660460749","title":"DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List","url":"https://stock-news.laohu8.com/highlight/detail?id=2660460749","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660460749?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:02","pubTimestamp":1787058120,"startTime":"0","endTime":"0","summary":"National recognition comes as Daré Bioscience advances a multi-product women’s health strategy across commercialization, clinical development and first-in-category innovationSAN DIEGO, Aug.  18, 2026 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/18/3346918/30757/en/dar%C3%A9-bioscience-ceo-sabrina-martucci-johnson-named-to-forbes-2026-50-over-50-innovation-list.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DARE","LU2308191902.HKD","BK4588","BK4007","DAR","LU0012050646.USD","LU0256331488.USD","LU0630314457.HKD","LU1803068623.USD","LU2211817866.USD","LU1721429741.USD","LU2380233275.USD","LU1721429402.USD","BK4189","BK4585","LU0345780950.USD","LU0345781412.USD","BK4584","LABU","LU0106261612.USD","FXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432587","title":"Veru Chief Scientific Officer Gary Barnette Acquires $4,841.82 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432587","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432587?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:26","pubTimestamp":1786998405,"startTime":"0","endTime":"0","summary":"Veru Chief Scientific Officer Gary Barnette acquires $4,841.82 in common sharesVeru: Chief Scientific Officer K Gary Barnette bought 1,800 common shares at USD 2.69 each.Directly owned common shares r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL8W9cTG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Veru Chief Scientific Officer Gary Barnette Acquires $4,841.82 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4557","BK4584","BK4007","BK4183","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660820480","title":"Daré Bioscience Prices USD 6 Million Registered Direct Offering at USD 1.37 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2660820480","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660820480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:36","pubTimestamp":1786970176,"startTime":"0","endTime":"0","summary":"Daré Bioscience prices USD 6 million registered direct offering at USD 1.37 per shareDaré Bioscience priced a registered direct offering of 4,379,581 common shares, or pre-funded warrants, at USD 1.37","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL9P7kcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","DARE","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660655484","title":"Teva price target raised to $42 from $40 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2660655484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660655484?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:59","pubTimestamp":1786964399,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Teva (TEVA) to $42 from $40 and keeps an Overweight rating on the shares post the Q2 report. The firm se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-price-target-raised-to-42-from-40-at-barclays-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-price-target-raised-to-42-from-40-at-barclays-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4585","BK4007","LU1983299246.USD","BK4566","LU2324357040.USD","BK4588","BK4557","TEVA","BK4596","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659827176","title":"Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659827176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659827176?lang=en_us&edition=fundamental","pubTime":"2026-08-16 02:30","pubTimestamp":1786818607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DAR...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-belite-bio-inc-adr-blte-and-dare-bioscience-dare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SAPH","AADR","XBI","BLTE","ARMH","DIVL","APIE","HCSG","LU0128526141.USD","BK4585","BK4137","LABU","DARE","BK4588","DINT","XLV","LU0029874061.USD","BK4007","BK4581","BK4584","CVY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659135121","title":"Femasys Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659135121","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659135121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:59","pubTimestamp":1786741167,"startTime":"0","endTime":"0","summary":"Femasys Inc reports results for the quarter ended June 30 - Earnings SummaryFemasys IncFEMY.OQreported a quarterly adjusted loss of $1.55 per share for the quarter ended June 30, higher than the same ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","BK4584","FEMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129844","title":"Evofem Q2 FY26 Net Loss Widens to $8.55 Million; Net Product Sales Fall 45% to $2.63 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129844","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129844?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:13","pubTimestamp":1786738420,"startTime":"0","endTime":"0","summary":"Evofem Q2 FY26 net loss widens to $8.55 million; net product sales fall 45% to $2.63 millionEvofem posted Q2 net product sales of $2.63 million, down 45% year over year.Cost of goods sold fell 32% to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL24jwrp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4584","EVFM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126762","title":"Femasys Q2 Net Loss Narrows 2.55% to $4.47 Million; Net Sales Drop 18.9% to $331,827","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126762","media":"Reuters","labels":["executive","shareholding","corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126762?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:06","pubTimestamp":1786738006,"startTime":"0","endTime":"0","summary":"Femasys Q2 net loss narrows 2.55% to $4.47 million; net sales drop 18.9% to $331,827Femasys posted a Q2 net loss of USD 4.47 million, or USD 1.33 per share, versus a year-earlier net loss of USD 4.59 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4GywSL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,shareholding,corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014013.SGD","LU2095319765.USD","BK4112","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BN0W2T93.GBP","BK4082","LU2210150020.SGD","IE00BGHQF748.EUR","BK4584","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4585","FEMY","IE00BN0W2V16.EUR","LU0314104364.USD","NDAQ","IE00B3QW5Z07.USD","BK4539","BCDF","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126229","title":"Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126229?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:05","pubTimestamp":1786737901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA4QFSV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4539","BK4584","FEMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123743","title":"Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123743","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123743?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:25","pubTimestamp":1786728312,"startTime":"0","endTime":"0","summary":"Dare Bioscience (DARE) said Friday it priced a registered direct offering of 4.4 million shares, or pre-funded warrants in lieu thereof, at $1.37 per share, with gross proceeds expected to be about $6","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4584","BK4007","DARE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123955","title":"Daré Bioscience to Issue Series A, Series B Warrants in Private Placement for up to 8,759,162 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123955","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123955?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:45","pubTimestamp":1786725920,"startTime":"0","endTime":"0","summary":"Daré Bioscience to issue Series A, Series B warrants in private placement for up to 8,759,162 sharesDaré Bioscience set a concurrent private placement of Series A warrants, Series B warrants, and unde","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLTx7Zt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BKPKM429.USD","BK4112","BCDF","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4584","NDAQ","IE00BN0W2W23.USD","SG9999014039.USD","DARE","BK4007","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659312395","title":"NASDAQ Trade Halt Volatility Trading Pause at 12:45 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2659312395","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659312395?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:45","pubTimestamp":1786725918,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 12:45 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nAQN2METN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DARE","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659932123","title":"DarÉ Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2659932123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659932123?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:45","pubTimestamp":1786725904,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA501QB8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DARE","BK4584","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659250951","title":"Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2659250951","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659250951?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:45","pubTimestamp":1786725900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Aug.  14, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising scienc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345541/30757/en/dar%C3%A9-bioscience-announces-pricing-of-6-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","DARE","BK4007","BK4584"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}